Steve Cohen: portfolio of Point72 Asset Management

Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 15, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2022. Go to the latest filing (Q3 2026)

20.9B USDQ2 2022
Total value of stock positions
20.9B USD
Positions
982
Share of the ten largest
10.1%

The ten largest positions Q2 2022

  1. T-Mobile US 1.8%▲ +116.8%
  2. Visa Inc. 1.3%▲ +49.6%
  3. Argenx SE 1.0%▼ −27.4%
  4. Take-Two Interactive 0.9%▲ +734.4%
  5. Fidelity National Information Services 0.9%▲ +35.2%
  6. ServiceNow 0.9%▲ +313.3%
  7. Arista Networks 0.8%▲ +14.0%
  8. Humana 0.8%▲ +45.1%
  9. Meta Platforms 0.8%▲ +145.6%
  10. ConocoPhillips 0.8%▼ −8.0%
Total value of stock positions per quarter, Q2 2014 to Q3 2026 (peak 62.9B USD).
Choose a quarter (50 filings)

All positions Q2 2022

Positions Q2 2022 per 13F filing, 50 of 260
Symbol Weight Shares Reported value Change Held since
Bunge Limited < 0.1% 83,900 7.6M USD −77.8% reduced Q2 2014 or earlier 33 quarters
Xenon Pharmaceuticals Inc 0.1% 901,506 27.4M USD −58.0% reduced Q1 2015 30 quarters
AMZN Amazon 0.7% 1,312,791 139.4M USD −25.0% reducedafter 20:1 stock split Q1 2017 22 quarters
BKNG Booking Holdings 0.5% 61,080 106.8M USD −59.6% reduced Q1 2018 18 quarters
Sanofi < 0.1% 315,984 15.8M USD −76.2% reduced Q1 2018 18 quarters
Insmed Inc 0.2% 1,660,854 32.8M USD −29.8% reduced Q3 2018 16 quarters
Select Sector SPDR TR 0.5% 1,390,000 99.4M USD −1.1% reduced Q1 2019 14 quarters
Arvinas Inc < 0.1% 411,548 17.3M USD −52.0% reduced Q1 2019 14 quarters
Childrens Pl Inc New < 0.1% 45,200 1.8M USD −61.1% reduced Q1 2019 14 quarters
JBL Jabil 0.5% 1,980,800 101.4M USD −34.4% reduced Q2 2019 13 quarters
Ideaya Biosciences Inc < 0.1% 1,509,000 20.8M USD −18.3% reduced Q2 2019 13 quarters
Cytokinetics Inc < 0.1% 19,633 771.0K USD −98.8% reduced Q2 2019 13 quarters
Affimed N V < 0.1% 6,449,020 17.9M USD −31.1% reduced Q3 2019 12 quarters
TRGP Targa Resources < 0.1% 287,342 17.1M USD −74.1% reduced Q3 2019 12 quarters
Bicycle Therapeutics PLC 0.1% 1,445,000 24.2M USD −10.8% reduced Q4 2019 11 quarters
Texas Roadhouse Inc 0.2% 456,956 33.4M USD −43.3% reduced Q1 2020 10 quarters
Ngm Biopharmaceuticals Inc < 0.1% 1,320,662 16.9M USD −58.9% reduced Q1 2020 10 quarters
Exelixis Inc < 0.1% 512,600 10.7M USD −92.5% reduced Q1 2020 10 quarters
Ishares TR < 0.1% 40,000 2.0M USD −46.7% reduced Q1 2020 10 quarters
MRK Merck & Co. 0.5% 1,196,400 109.1M USD −66.6% reduced Q2 2020 9 quarters
Krystal Biotech Inc 0.5% 1,574,275 103.4M USD −8.5% reduced Q2 2020 9 quarters
ADI Analog Devices 0.4% 571,516 83.5M USD −60.0% reduced Q2 2020 9 quarters
Relmada Therapeutics Inc 0.1% 1,272,574 24.2M USD −3.0% reduced Q2 2020 9 quarters
WRB W. R. Berkley Corporation < 0.1% 129,461 8.8M USD −50.8% reduced Q2 2020 9 quarters
Ringcentral Inc < 0.1% 4,421 231.0K USD −98.1% reduced Q2 2020 9 quarters
COP ConocoPhillips 0.8% 1,823,600 163.8M USD −8.0% reduced Q3 2020 8 quarters
Antero Resources Corp 0.3% 2,125,177 65.1M USD −22.8% reduced Q3 2020 8 quarters
Capri Holdings Limited 0.2% 1,177,370 48.3M USD −34.4% reduced Q3 2020 8 quarters
CSX CSX Corporation 0.2% 1,595,201 46.4M USD −19.4% reduced Q3 2020 8 quarters
Biomarin Pharmaceutical Inc < 0.1% 147,871 12.3M USD −59.7% reduced Q3 2020 8 quarters
ASML ASML Holding (ADR) < 0.1% 19,921 9.5M USD −52.0% reduced Q3 2020 8 quarters
WDC Western Digital < 0.1% 189,803 8.5M USD −31.0% reduced Q3 2020 8 quarters
SHIFT4 Pmts Inc < 0.1% 174,352 5.8M USD −56.4% reduced Q3 2020 8 quarters
Transalta Corp < 0.1% 385,000 4.4M USD −63.8% reduced Q3 2020 8 quarters
Signet Jewelers Limited < 0.1% 64,835 3.5M USD −75.1% reduced Q3 2020 8 quarters
CRL Charles River Laboratories < 0.1% 14,513 3.1M USD −81.5% reduced Q3 2020 8 quarters
Nanostring Technologies Inc < 0.1% 149,989 1.9M USD −41.5% reduced Q3 2020 8 quarters
Azure Pwr Global Ltd < 0.1% 161,500 1.8M USD −33.1% reduced Q3 2020 8 quarters
MA Mastercard 0.2% 163,726 51.7M USD −45.7% reduced Q4 2020 7 quarters
Post HLDGS Inc 0.2% 536,921 44.2M USD −54.7% reduced Q4 2020 7 quarters
Atara Biotherapeutics Inc 0.1% 3,877,200 30.2M USD −5.5% reduced Q4 2020 7 quarters
Angiodynamics Inc < 0.1% 927,203 17.9M USD −19.0% reduced Q4 2020 7 quarters
Ultragenyx Pharmaceutical In < 0.1% 273,515 16.3M USD −14.1% reduced Q4 2020 7 quarters
Array Technologies Inc < 0.1% 823,790 9.1M USD −35.6% reduced Q4 2020 7 quarters
Under Armour Inc < 0.1% 828,566 6.9M USD −63.8% reduced Q4 2020 7 quarters
Cytomx Therapeutics Inc < 0.1% 2,750,000 5.0M USD −37.1% reduced Q4 2020 7 quarters
Alphatec HLDGS Inc < 0.1% 711,300 4.7M USD −13.6% reduced Q4 2020 7 quarters
Lpl Finl HLDGS Inc < 0.1% 10,800 2.0M USD −83.9% reduced Q4 2020 7 quarters
Fusion Pharmaceuticals Inc < 0.1% 328,868 819.0K USD −6.0% reduced Q4 2020 7 quarters
Praxis Precision Medicines I < 0.1% 100,000 245.0K USD −92.5% reduced Q4 2020 7 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 longest-held of 260 positions.

Plus 358 option positions, value of the underlying shares as reported 2.4B USD – not included in the weights.

The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.

  • SPDR S&P 500 ETF TR Put 643.9M USD
  • Invesco Db Multi-Sector Comm Call 96.1M USD
  • Select Sector SPDR TR Call 57.1M USD
  • Alibaba Group (ADR) Call 48.3M USD
  • Deere & Company Call 44.9M USD
  • Ishares TR Put 34.1M USD
  • American Airls Group Inc Put 30.2M USD
  • SPDR Ser TR Put 29.9M USD
  • Kohls Corp Call 28.6M USD
  • SPDR S&P 500 ETF TR Call 28.3M USD
Plus 38 positions in convertible bonds and bonds worth 350.2M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Novavax Inc principal 31.9M USD 32.0M USD
  • Dish Network Corporation principal 37.0M USD 26.2M USD
  • Spotify USA Inc principal 29.5M USD 23.5M USD
  • Sarepta Therapeutics Inc principal 17.0M USD 21.5M USD
  • Lumentum HLDGS Inc principal 20.0M USD 20.6M USD
  • Docusign Inc principal 17.5M USD 16.2M USD
  • Sunnova Energy Intl Inc. principal 18.3M USD 14.3M USD
  • Wayfair Inc principal 17.5M USD 14.0M USD
  • Wayfair Inc principal 20.5M USD 13.8M USD
  • Ford Mtr Co Del principal 15.0M USD 13.7M USD

Breakdown by sector

  • Technology 10.0%
  • Consumer Discretionary 7.5%
  • Health Care 7.2%
  • Financials 6.2%
  • Industrials 4.9%
  • Communication Services 4.0%
  • Consumer Staples 3.4%
  • Utilities 3.3%
  • Energy 2.6%
  • Materials 1.8%
  • Real Estate 1.4%
  • not in our coverage 47.6%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close